NEW YORK — Pfizer Inc. (NYSE: PFE) has announced that it has entered into a manufacturing capacity reservation agreement with the European Health and Digital Executive Agency (HaDEA) of the European Commission (EC), which provides the European Union (EU) access to doses of a mRNA-based vaccine should one be developed to protect against a future pandemic-causing disease. The agreement is …
NEW YORK— Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have reached an agreement with the European Commission (EC) to amend their existing contract to deliver Covid-19 vaccines to the European Union. The amended agreement reflects the companies’ commitment to working collaboratively to help address ongoing public health needs, while respecting the principles of the original …
Contractually remaining doses of Moderna’s COVID-19 vaccine (Spikevax, mRNA-1273) will be converted to Moderna’s next generation Omicron-containing bivalent vaccines CAMBRIDGE – Moderna, Inc.(NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an amendment to its agreement with the European Commission (EC) to convert contractually agreed doses of Moderna’s COVID-19 vaccine (Spikevax, mRNA-1273) to the Company’s Omicron-containing …
CAMBRIDGE – Moderna, Inc, (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending a variation to the conditional marketing authorization (CMA) to include a booster dose of Spikevax, the Company’s COVID-19 vaccine, at the 50 µg …
Los Angeles – Food and Drug Administration has announced that an advisory committee is set to meet June 7 to examine the benefits and risks of Novavax Inc’s experimental Covid-19 vaccine. Novavax’s protein-based vaccine has been authorized in several countries, including by the UK and the European Commission, but is still being reviewed by the FDA. The company’s stock has …
